Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:1252-1260
Published online before print October 26, 2006, doi: 10.1161/01.RES.0000250821.32324.e1
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/11/1252    most recent
01.RES.0000250821.32324.e1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishiguro, M.
Right arrow Articles by Wellman, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishiguro, M.
Right arrow Articles by Wellman, G. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*4-AMINOPYRIDINE
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Ion channels/membrane transport
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Other Vascular biology
(Circulation Research. 2006;99:1252.)
© 2006 American Heart Association, Inc.


Integrative Physiology

Oxyhemoglobin-Induced Suppression of Voltage-Dependent K+ Channels in Cerebral Arteries by Enhanced Tyrosine Kinase Activity

Masanori Ishiguro, Anthony D. Morielli, Katarina Zvarova, Bruce I. Tranmer, Paul L. Penar, George C. Wellman

From the Department of Pharmacology (M.I., A.D.M., K.Z., G.C.W.); and Department of Surgery (B.I.T., P.L.P., G.C.W.), Division of Neurological Surgery, University of Vermont College of Medicine, Burlington.

Correspondence to George C. Wellman, PhD, University of Vermont, Department of Pharmacology, Given Bldg, 89 Beaumont Ave, Burlington, VT 05405-0068. E-mail george.wellman{at}uvm.edu

Cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) has devastating consequences. Oxyhemoglobin (oxyhb) has been implicated in SAH-induced cerebral vasospasm as it causes cerebral artery constriction and increases tyrosine kinase activity. Voltage-dependent, Ca2+-selective and K+-selective ion channels play an important role in the regulation of cerebral artery diameter and represent potential targets of oxyhb. Here we provide novel evidence that oxyhb selectively decreases 4-aminopyridine sensitive, voltage-dependent K+ channel (Kv) currents by {approx}30% in myocytes isolated from rabbit cerebral arteries but did not directly alter the activity of voltage-dependent Ca2+ channels or large conductance Ca2+-activated (BK) channels. A combination of tyrosine kinase inhibitors (tyrphostin AG1478, tyrphostin A23, tyrphostin A25, genistein) abolished both oxyhb-induced suppression of Kv channel currents and oxyhb-induced constriction of isolated cerebral arteries. The Kv channel blocker 4-aminopyridine also inhibited oxyhb-induced cerebral artery constriction. The observed oxyhb-induced decrease in Kv channel activity could represent either channel block, or a decrease in Kv channel density on the plasma membrane. To explore whether oxyhb altered trafficking of Kv channels to the plasma membrane, we used an antibody generated against an extracellular epitope of Kv1.5 channels. In the presence of oxyhb, staining of Kv1.5 on the plasma membrane surface was markedly reduced. Furthermore, oxyhb caused a loss of spatial distinction between staining with Kv1.5 and the general anti-phosphotyrosine antibody PY-102. We propose that oxyhb-induced suppression of Kv currents occurs via a mechanism involving enhanced tyrosine kinase activity and channel endocytosis. This novel mechanism may contribute to oxyhb-induced cerebral artery constriction following SAH.


Key Words: voltage-dependent potassium channels • vascular smooth muscle • cerebral arteries • subarachnoid hemorrhage • oxyhemoglobin




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Luykenaar, R. A. El-Rahman, M. P. Walsh, and D. G. Welsh
Rho-kinase-mediated suppression of KDR current in cerebral arteries requires an intact actin cytoskeleton
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H917 - H926.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. E. Link, K. Murakami, M. Beem-Miller, B. I. Tranmer, and G. C. Wellman
Oxyhemoglobin-Induced Expression of R-Type Ca2+ Channels in Cerebral Arteries
Stroke, July 1, 2008; 39(7): 2122 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Koide, P. L. Penar, B. I. Tranmer, and G. C. Wellman
Heparin-binding EGF-like growth factor mediates oxyhemoglobin-induced suppression of voltage-dependent potassium channels in rabbit cerebral artery myocytes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1750 - H1759.
[Abstract] [Full Text] [PDF]